Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer

已完结 20 由不可一世发布于 2026/4/2 10:27:47

DOI:10.1158/1078-0432.ccr-25-3321
作者：Dileep Reddy. Rampa, Minji Seo, Nanae Ogata, Zhaoxuan Yang, Nithya Sridhar, Fujii Takeo, Chalothorn Wannaphut, Jennifer A. Maynard, Kyoji Tsuchikama, George W. Sledge, Naoto T. Ueno, Jangsoon Lee
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：Purpose: Antibody–drug conjugates (ADCs) have transformed the treatment of breast cancer. FDA-approved ADCs such as trastuzumab deruxtecan (T-DXd), sacituzumab govitecan (SG), and datopotama

应助信息

2小时前

Quartz

202604021703592739089.pdf 已采纳

9小时前

Book学术机器人

202602040923373603086.zip 已驳回

9小时前

Book学术机器人

2026/4/2 10:27:47 Book学术AI机器人已找到文献并上传

2026/4/2 10:27:47 Book学术AI机器人收到请求，开始寻找文献

2026/4/2 10:27:47 已向机器人发送请求

9小时前

不可一世发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Understanding and Controlling the Trace Iron Incorporation during Th-Rhabdophane Crystallization